In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...
After underperforming throughout 2024, shares of CVS Health (NYSE: CVS) are surging. From the end of 2024 through Feb. 14, ...
CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...
CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business ...
CVS Health has eliminated more than 1,000 jobs based at or reporting to its offices in Hartford, which include the ...
CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...
Some analysts are more optimistic about CVS’ ability to navigate higher-than-expected medical costs in its insurance unit ...
CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...
CVS Health reported a smaller-than-expected drop in fourth-quarter profit on Wednesday as the pace of medical cost increases ...
CVS Health investors were breathing a big sigh of relief Wednesday after the healthcare services behemoth reported ...
CVS Health (NYSE:CVS – Free Report) had its price target lifted by JPMorgan Chase & Co. from $80.00 to $81.00 in a report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results